Calgary, Alberta – April 16, 2024 – TheNewswire – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) is pleased to announce that on April 16, 2024 the Board of Directors approved the previously-announced (March 14, 2024) agreement to acquire 100% of Mindbalanced Inc. (“MB”) of the State of Florida, USA. The terms and conditions of the transaction as set out in the previous release remain essentially the same and the Canadian Securities Exchange (“CSE”) has informed the Corporation that the transaction, as structured, does not require CSE approval. Consistent with the terms and conditions of the transaction, Dr. Keith Courtney has resigned as the Corporation’s President and is replaced by Joshua Hill. Dr. Courtney will remain as the Corporation’s Chief Psychiatric Officer. Mr. Hill will also become a member of the Corporation’s Board of Directors and it is expected that Mr. Hill will nominate one other Director in due course.

Jim Durward, CEO, states: “I’m extremely happy with this transaction. Not only is it low risk for nDatalyze, but it offers significant near-term revenue potential as well as a market penetration point for our advanced YMI analytical tool. As President, Josh Hill can now apply his experience in specialty pharmaceuticals and complex regulatory landscapes to drive the Corporation forward. Once Josh has settled into his new position I expect he will be announcing more details as to his plans for the future.”

For Further Information about this transaction, please contact:

James Durward, CEO&CTO

Tel: (403) 689-3901

Email: jimd@ndatalyze.com    

nDatalyze Website: https://www.ndatalyze.com      

About YMI: YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops, and how to improve mental wellbeing. YMI combines supervised machine-learning with a proprietary Reference Database to predict an individual’s predisposition toward a variety of common mental conditions, both current and forward in time. YMI is poised to revolutionize mental health diagnoses while ensuring a sustainable revenue stream. By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies, and targeting key markets, YMI aligns both societal impact and financial success.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.